Enhancer of zeste homolog 2 (Ezh2) is required in mouse Isl1-expressing progenitors for proper development of cardiac and skeletal hindlimb structures
Biology Open · 2026
DOI: 10.1242/bio.062550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, 2026. Verfasst von Hamna Ammar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine, The Hospital for Sick Children, Toronto, ON M5G0A4, Canada. Hauptthemen laut MEDLINE: LIM-Homeodomain Proteins, Transcription Factors, Enhancer of Zeste Homolog 2 Protein, Hindlimb. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Heart and Stroke Foundation of Canada, Heart & Stroke Foundation of Canada.
Abstract (Originalsprache)
Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb Repressive Complex 2, catalyses H3K27 trimethylation and directs lineage development programs, yet its function in early multipotent progenitors remains incompletely understood. ISL1 marks cardiopharyngeal and neural crest progenitors that contribute to second heart field derivatives and to craniofacial and limb morphogenesis. Here, Isl1-cre lineage tracing showed that lineage derivatives populated the cardiopharyngeal region and the posteromedial hindlimb bud during mid-gestation, and contributed extensively to the developing right ventricle, outflow tract, and hindlimb. Loss of Ezh2 in Isl1-expressing progenitors resulted in a high incidence of congenital heart defects, dominated by incomplete atrial and ventricular septation and outflow tract malformations, including double outlet right ventricle and persistent truncus arteriosus. These defects were accompanied by ventricular wall thickening at birth. In parallel, Ezh2 mutants exhibited hindlimb skeletal abnormalities, including pelvic and tarsal malformations with impaired ossification. These abnormalities were associated with cyanosis and perinatal demise. Together, these findings identify a requirement for EZH2 in Isl1-lineage contribution to heart and hindlimb development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine, The Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
- Institute of Medical Sciences, University of Toronto, Toronto, ON M5S1A8, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, ON M5S1A8, Canada.
- Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research, Toronto, ON M5S3H2, Canada.
ORCID-Profile: Paul Delgado-Olguín
Förderung
- CIHR
- Heart and Stroke Foundation of Canada
- Heart & Stroke Foundation of Canada
- University of Toronto
- Canadian Institutes of Health Research
Zitieren
APA
Ammar, H., Patolsky, D. B., Chi, L., Caballero, A. N., & Delgado-Olguín, P. (2026). Enhancer of zeste homolog 2 (Ezh2) is required in mouse Isl1-expressing progenitors for proper development of cardiac and skeletal hindlimb structures. Biology Open. https://doi.org/10.1242/bio.062550
Vancouver
Ammar H, Patolsky DB, Chi L, Caballero AN, Delgado-Olguín P. Enhancer of zeste homolog 2 (Ezh2) is required in mouse Isl1-expressing progenitors for proper development of cardiac and skeletal hindlimb structures. Biology Open. 2026. doi:10.1242/bio.062550
BibTeX
@article{Ammar2026,
author = {Ammar, Hamna and Patolsky, Daniel B and Chi, Lijun and Caballero, Amalia N and Delgado-Olguín, Paul},
title = {Enhancer of zeste homolog 2 (Ezh2) is required in mouse Isl1-expressing progenitors for proper development of cardiac and skeletal hindlimb structures},
journal = {Biology Open},
year = {2026},
doi = {10.1242/bio.062550}
}
EUVIMED